Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tsoukas

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Nature Medicine|May 13, 2022
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trialAhmad Haidar, Leif Erik Lovblom, Nancy Cardinez, et al.
The Lancet. Digital Health|June 21, 2024
Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, CanadaElisa Cohen, Michael A Tsoukas, Laurent Legault, et al.
Diabetes, Obesity & Metabolism|May 28, 2021
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studiesMichael A Tsoukas, Elisa Cohen, Laurent Legault, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Circulating irisin in relation to insulin resistance and the metabolic syndromeKyung Hee Park, Lesya Zaichenko, Mary Brinkoetter, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2025
Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 DiabetesMagdalena Sevilla-González, Paul A Hanson, Jesse Islam, et al.
Diabetologia|February 3, 2016
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trialOlivia M Farr, Michail Sofopoulos, Michael A Tsoukas, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.
Diabetologia|December 15, 2025
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetesAlessandra Kobayati, Michael A Tsoukas, Natasha Garfield, et al.
The New England Journal of Medicine|March 19, 2025
A Randomized Trial of Automated Insulin Delivery in Type 2 DiabetesYogish C Kudva, Dan Raghinaru, John W Lum, et al.
Obstetrical & Gynecological Survey|December 30, 2025
A Randomized Trial of Automated Insulin Delivery in Type 2 DiabetesYogish C Kudva, Dan Raghinaru, John W Lum, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Nature Medicine|May 13, 2022
Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trialAhmad Haidar, Leif Erik Lovblom, Nancy Cardinez, et al.
The Lancet. Digital Health|June 21, 2024
Simple meal announcements and pramlintide delivery versus carbohydrate counting in type 1 diabetes with automated fast-acting insulin aspart delivery: a randomised crossover trial in Montreal, CanadaElisa Cohen, Michael A Tsoukas, Laurent Legault, et al.
Diabetes, Obesity & Metabolism|May 28, 2021
Alleviating carbohydrate counting with a FiASP-plus-pramlintide closed-loop delivery system (artificial pancreas): Feasibility and pilot studiesMichael A Tsoukas, Elisa Cohen, Laurent Legault, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2013
Circulating irisin in relation to insulin resistance and the metabolic syndromeKyung Hee Park, Lesya Zaichenko, Mary Brinkoetter, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2025
Compartment-Specific Metabolic Alterations to Insulin Reflect Adiposity-Driven Variation and Predict Type 2 DiabetesMagdalena Sevilla-González, Paul A Hanson, Jesse Islam, et al.
Diabetologia|February 3, 2016
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trialOlivia M Farr, Michail Sofopoulos, Michael A Tsoukas, et al.
Diabetes, Obesity & Metabolism|February 2, 2021
Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trialAhmad Haidar, Jean-Francois Yale, Leif Erik Lovblom, et al.
Diabetologia|December 15, 2025
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetesAlessandra Kobayati, Michael A Tsoukas, Natasha Garfield, et al.
The New England Journal of Medicine|March 19, 2025
A Randomized Trial of Automated Insulin Delivery in Type 2 DiabetesYogish C Kudva, Dan Raghinaru, John W Lum, et al.
Obstetrical & Gynecological Survey|December 30, 2025
A Randomized Trial of Automated Insulin Delivery in Type 2 DiabetesYogish C Kudva, Dan Raghinaru, John W Lum, et al.
Pageof 9